meloxicam
-
Malvern-Based Recro Pharma Sees Its Stock Plummet 34 Percent
Malvern-based Recro Pharma saw its stock plunge by more than 34 percent after the Food and Drug Administration rejected its new drug application for a…
-
Test Results on Non-Opioid Pain Med Bode Well for Malvern’s Recro Pharma
Recro Pharma’s latest drug test felt more like a shot of adrenaline than a sigh of relief when patients noted they were well aware of…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
